Skip to main content
Equibles

STATE STREET CORP

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$20,271,393
-$210,316 QoQ
Shares Held
4,354,757
+22.0% QoQ
Ownership
5.31%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 141 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 7% Shared 0% None 93%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. LXEO ranks #162 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in LXEO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,271,393 4,354,757
2026-03-31 $20,481,709 3,568,242
2025-12-31 $31,654,079 3,187,722
2025-09-30 $3,617,770 544,845
2025-06-30 $2,062,364 513,026
2025-03-31 $1,629,956 469,728
2024-12-31 $3,009,711 457,403
2024-09-30 $2,295,671 253,946
2024-06-30 $3,148,202 196,272
2024-03-31 $1,759,531 112,215